Metoprolol and Ivabradine During Breastfeeding
Metoprolol is safe to use during breastfeeding, but ivabradine should be avoided—you must choose between taking ivabradine or breastfeeding.
Metoprolol: Compatible with Breastfeeding
Metoprolol is considered safe for lactating mothers based on multiple lines of evidence:
Metoprolol is a preferred beta-blocker during breastfeeding 1. It has high protein binding, which results in lower milk-to-plasma ratios and minimal infant exposure 2.
A 2016 pharmacokinetic study demonstrated that relative infant exposure through breast milk was less than 1.0% of the maternal weight-adjusted dose 3. This is well below the theoretical 10% threshold considered safe for breastfed infants.
A large 2024 prospective study of beta-blockers during breastfeeding found no serious adverse events in breastfed infants whose mothers took beta-blockers, including metoprolol 4. This real-world evidence is particularly reassuring.
Current guidelines identify metoprolol (along with labetalol) as a drug of choice for heart rate control in breastfeeding mothers 1.
Clinical approach: Continue metoprolol at your current dose. Monitor the infant for signs of beta-blockade (bradycardia, lethargy, poor feeding), though these are unlikely given the low milk transfer.
Ivabradine: Not Compatible with Breastfeeding
The FDA drug label is explicit and unequivocal about ivabradine:
"It is not known if ivabradine passes into breast milk. You and your doctor should decide if you will take ivabradine tablets or breastfeed; do not do both" 5.
The FDA label states: "Because of the potential risk to breastfed infants from exposure to ivabradine, breastfeeding is not recommended" 5.
Animal studies show ivabradine is present in rat milk at concentrations 1.5-1.8 times higher than plasma levels 5, suggesting significant milk transfer.
There are no human studies on ivabradine transfer into breast milk or effects on breastfed infants.
Critical caveat: The evidence provided includes studies on ivabradine combined with metoprolol for angina 6 and pediatric use 7, but these do not address lactation safety. The only relevant evidence is the FDA contraindication.
Your Decision Algorithm
If heart rate control is adequate on metoprolol alone: Discontinue ivabradine and continue breastfeeding on metoprolol.
If inadequate heart rate control on metoprolol alone:
- Consider increasing metoprolol dose (pregnancy causes increased clearance, so postpartum dose optimization may be needed 3)
- Consider adding a second compatible agent (calcium channel blockers like extended-release nifedipine are safe during breastfeeding 1)
- If ivabradine is medically essential, discontinue breastfeeding
Do not attempt to "pump and dump" with ivabradine—there is no established safe waiting period, and the drug's pharmacokinetics in milk are unknown.
Common Pitfall to Avoid
Do not assume that because metoprolol is safe, ivabradine will be similarly safe. These are entirely different drug classes with different pharmacokinetic properties. The HCN channel blocker ivabradine has no established safety data in lactation, while beta-blockers like metoprolol have decades of reassuring evidence.